Compounds > 3-hydroxy-3-methylglutaryl-coenzyme a

3-hydroxy-3-methylglutaryl-coenzyme a and Bone Cancer

3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Bone Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Li, W; Li, Y; Liu, H; Wang, Z1
Altundag, K; Bulut, N; Dincer, M; Harputluoglu, H1

Other Studies

2 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Bone Cancer

ArticleYear
Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo.
    Neoplasma, 2013, Volume: 60, Issue:3

    Topics: Acyl Coenzyme A; Adenocarcinoma; Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Bone Neoplasms; Cell Proliferation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin; Tumor Cells, Cultured

2013
Statins may decrease skeletal-related events in breast cancer patients with bone metastases.
    Medical hypotheses, 2006, Volume: 67, Issue:5

    Topics: Acyl Coenzyme A; Apoptosis; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Cell Division; Cholesterol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Neoplasm Metastasis; Osteoclasts

2006